Tender detail
Non-exclusive rebate agreement for propranolol
Summary
The tender concerns the conclusion of a non-exclusive rebate agreement for the active substance propranolol, exclusively the LSE dosage form, for the period 01/07/2026 to 30/06/2028. DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible for the medicines named by the bidder in the contract appendix.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.